Interchange Capital Partners LLC Has $618,000 Position in Intuitive Surgical, Inc. $ISRG

Interchange Capital Partners LLC lifted its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 5.6% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,138 shares of the medical equipment provider’s stock after purchasing an additional 60 shares during the quarter. Interchange Capital Partners LLC’s holdings in Intuitive Surgical were worth $618,000 at the end of the most recent quarter.

A number of other hedge funds also recently modified their holdings of the business. Cabot Wealth Management Inc. acquired a new stake in shares of Intuitive Surgical during the second quarter worth about $4,285,000. Brighton Jones LLC grew its holdings in shares of Intuitive Surgical by 33.3% during the second quarter. Brighton Jones LLC now owns 5,047 shares of the medical equipment provider’s stock worth $2,742,000 after buying an additional 1,260 shares in the last quarter. AG2R LA Mondiale Gestion D Actifs grew its holdings in shares of Intuitive Surgical by 1.6% during the second quarter. AG2R LA Mondiale Gestion D Actifs now owns 13,420 shares of the medical equipment provider’s stock worth $7,293,000 after buying an additional 213 shares in the last quarter. State of New Jersey Common Pension Fund D grew its holdings in shares of Intuitive Surgical by 0.3% during the second quarter. State of New Jersey Common Pension Fund D now owns 120,616 shares of the medical equipment provider’s stock worth $65,544,000 after buying an additional 356 shares in the last quarter. Finally, Richards Merrill & Peterson Inc. grew its holdings in shares of Intuitive Surgical by 17.4% during the second quarter. Richards Merrill & Peterson Inc. now owns 3,318 shares of the medical equipment provider’s stock worth $1,803,000 after buying an additional 491 shares in the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insiders Place Their Bets

In other Intuitive Surgical news, insider Gary S. Guthart sold 29,360 shares of the firm’s stock in a transaction on Friday, August 29th. The stock was sold at an average price of $472.49, for a total transaction of $13,872,306.40. Following the completion of the sale, the insider owned 19,827 shares of the company’s stock, valued at $9,368,059.23. This trade represents a 59.69% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Amy L. Ladd sold 335 shares of the firm’s stock in a transaction on Thursday, September 4th. The shares were sold at an average price of $440.69, for a total value of $147,631.15. Following the sale, the director directly owned 739 shares of the company’s stock, valued at $325,669.91. This represents a 31.19% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 40,724 shares of company stock worth $19,500,332. 0.70% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

A number of research analysts recently issued reports on the company. Evercore ISI decreased their price objective on Intuitive Surgical from $535.00 to $450.00 and set an “in-line” rating for the company in a report on Tuesday, October 7th. BTIG Research increased their price objective on Intuitive Surgical from $529.00 to $589.00 and gave the stock a “buy” rating in a report on Wednesday. Sanford C. Bernstein reiterated an “outperform” rating and set a $685.00 price objective on shares of Intuitive Surgical in a report on Tuesday. HSBC increased their price objective on Intuitive Surgical from $595.00 to $644.00 and gave the stock a “buy” rating in a report on Thursday. Finally, Wells Fargo & Company increased their price objective on Intuitive Surgical from $599.00 to $600.00 and gave the stock an “overweight” rating in a report on Wednesday. One research analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating, eight have assigned a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, Intuitive Surgical currently has a consensus rating of “Moderate Buy” and a consensus price target of $602.32.

Intuitive Surgical Stock Down 0.9%

ISRG stock opened at $546.51 on Friday. The business has a 50 day moving average price of $458.09 and a two-hundred day moving average price of $497.29. The company has a market cap of $195.91 billion, a price-to-earnings ratio of 72.29, a P/E/G ratio of 5.45 and a beta of 1.61. Intuitive Surgical, Inc. has a twelve month low of $425.00 and a twelve month high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share for the quarter, beating analysts’ consensus estimates of $1.99 by $0.41. The firm had revenue of $2.51 billion during the quarter, compared to the consensus estimate of $2.41 billion. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.The business’s revenue was up 22.9% compared to the same quarter last year. During the same period last year, the company earned $1.84 earnings per share. On average, equities research analysts anticipate that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.